Publications

• Evolution of Systemic Therapy in Metastatic Pancreatic Ductal Adenocarcinoma.

  (Kamgar M, Chakrabarti S, Shreenivas A, George B.) Surg Oncol Clin N Am. 2021 Oct;30(4):673-691 PMID: 34511189 SCOPUS ID: 2-s2.0-85111041414 09/14/2021

• TAS-102: A resurrected novel Fluoropyrimidine with expanding role in the treatment of gastrointestinal malignancies.

  (Chakrabarti S, Wintheiser G, Tella SH, Oxencis C, Mahipal A.) Pharmacol Ther. 2021 Aug;224:107823 PMID: 33667525 SCOPUS ID: 2-s2.0-85102047484 03/06/2021

• Outcomes on anti-VEGFR-2/paclitaxel treatment after progression on immune checkpoint inhibition in patients with metastatic gastroesophageal adenocarcinoma.

  (Kankeu Fonkoua LA, Chakrabarti S, Sonbol MB, Kasi PM, Starr JS, Liu AJ, Nevala WK, Maus RL, Bois MC, Pitot HC, Chandrasekharan C, Ross HJ, Wu TT, Graham RP, Villasboas JC, Weiss M, Foster NR, Markovic SN, Dong H, Yoon HH.) Int J Cancer. 2021 07 15;149(2):378-386 PMID: 33739449 PMCID: PMC8488901 03/20/2021

• A Patient With Locally Advanced Mismatch-Repair-Deficient Pancreatic Ductal Adenocarcinoma Successfully Treated With Neoadjuvant Immunotherapy.

  (Cox RE Jr, Mahipal A, Chakrabarti S.) Cureus. 2021 Apr 22;13(4):e14640 PMID: 34055508 PMCID: PMC8144075 06/01/2021

• Prognostic variables in low and high risk stage III colon cancers treated in two adjuvant chemotherapy trials.

  (Sinicrope FA, Chakrabarti S, Laurent-Puig P, Huebner L, Smyrk TC, Tabernero J, Mini E, Goldberg RM, Zaanan A, Folprecht G, Van Laethem JL, Le Malicot K, Shi Q, Alberts SR, Taieb J.) Eur J Cancer. 2021 02;144:101-112 PMID: 33341444 PMCID: PMC7855426 12/21/2020

• The Promise of Circulating Tumor DNA (ctDNA) in the Management of Early-Stage Colon Cancer: A Critical Review.

  (Chakrabarti S, Xie H, Urrutia R, Mahipal A.) Cancers (Basel). 2020 09 29;12(10) PMID: 33003583 PMCID: PMC7601010 10/03/2020

• Early stage colon cancer: Current treatment standards, evolving paradigms, and future directions.

  (Chakrabarti S, Peterson CY, Sriram D, Mahipal A.) World J Gastrointest Oncol. 2020 Aug 15;12(8):808-832 PMID: 32879661 PMCID: PMC7443846 09/04/2020

• Targeted Therapies in Advanced Biliary Tract Cancer: An Evolving Paradigm.

  (Chakrabarti S, Kamgar M, Mahipal A.) Cancers (Basel). 2020 Jul 24;12(8) PMID: 32722188 PMCID: PMC7465131 07/30/2020

• Phase II Trial of Trifluridine/Tipiracil in Patients with Advanced, Refractory Biliary Tract Carcinoma.

  (Chakrabarti S, Zemla TJ, Ahn DH, Ou FS, Fruth B, Borad MJ, Hartgers ML, Wessling J, Walkes RL, Alberts SR, McWilliams RR, Liu MC, Durgin LM, Bekaii-Saab TS, Mahipal A.) Oncologist. 2020 05;25(5):380-e763 PMID: 31826977 PMCID: PMC7216452 12/13/2019

• Clinicopathological features and outcomes of fibrolamellar hepatocellular carcinoma.

  (Chakrabarti S, Tella SH, Kommalapati A, Huffman BM, Yadav S, Riaz IB, Goyal G, Mody K, Borad M, Cleary S, Smoot RL, Mahipal A.) J Gastrointest Oncol. 2019 Jun;10(3):554-561 PMID: 31183207 PMCID: PMC6534717 06/12/2019

• How I Treat Metastatic Colorectal Cancer With Maintenance Therapies.

  (Chakrabarti S, Hubbard JM. .) Handbook of Gastrointestinal Cancers Evidence-Based Treatment and Multidisciplinary Patient Care. Bekaii-Saab T, editor. USA: Springer Publishing; 2019. Chapter 15; p.116-121.. 08/01/2019

• Intratumoral CD3+ and CD8+ T-Cell Densities in Patients With DNA Mismatch Repair–Deficient Metastatic Colorectal Cancer Receiving Programmed Cell Death-1 Blockade

  (Sakti Chakrabarti, MD; Lucas J. Huebner; Heidi D. Finnes, PharmD; Andrea Muranyi, PhD2; June Clements, MD; Shalini Singh, DNB, MD; Joleen M. Hubbard, MD; Robert R. McWilliams, MD; Kandavel Shanmugam, PhD; and Frank A. Sinicrope, MD.) JCO Precision Oncology, Vol.3; p 1-7. 06/28/2019